TCTR20240513001已完成4 期
Comparison the Clinical Effectiveness of Radial Shockwave Therapy and Ultrasound Therapy for Treatment of Chronic De Quervain Disease
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 28
研究概览
简要总结
Baseline characteristic datas were no statistically significant difference between group. Both group showed statistically improvement of VAS, PRWE scores after intervention and 3 weeks post intervention but no statistically significant difference when compared between groups. Pinch strength also showed improvement at 3 weeks post intervention in both group.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)(—)
- 性别
- All
入选标准
- •1.Patient diagnosed with de quervain disease with tender point at 1st dorsal compartment area and positive finkelstein's test
- •2. Duration of symptoms more than 3 months
- •3. VAS 4-8
- •4. Age more than 18
排除标准
- •1. Contraindication for shockwave and ultrasound therapy
- •2. history of steroid injection or surgical at wrist
- •3. history of wrist-finger fracture
- •4. rheumatological or neurological disease causing wrist pain
研究者
相似试验
招募中
不适用
Efficiency evaluation of coronary computed tomography by using transdermal patch beta-blocker (high rate)Ischemic heart diseaseJPRN-UMIN000035246Saitama memorial hospital63
招募中
不适用
Comparizon of the clinical results using two different suture technique during arthroscopic Bankart repair.recurrent anterior shoulder instabilityJPRN-UMIN000035425Fukuoka University Chikushi Hospital40
已完成
2 期
Phase 2a Clinical Study to evaluate efficacy and safety of JTE-451 ointment in patients with plaque psoriasis.Plaque PsoriasisJPRN-jRCT2031210232Miwa Yasushi67
已完成
不适用
The comparison of the clinical effect between retrolaminar block and erector spinae plane blockJPRN-UMIN000033790Sapporo Medical University School of Medicine50
已完成
不适用
Study for variations of safety and efficacy profile caused by division of weekly dose of methotrexate (preliminary study)Rheumatoid arthritisJPRN-UMIN000012473Yokohama Minami Kyousai Hospital Santen Pharmaceutical CO.,Ltd.40
